A Multi-center Study to Compare PT007 to Placebo MDI and Open-Label Proventil ® HFA in Adult and Adolescent Subjects With Asthma

Condition:   Asthma Interventions:   Drug: AS MDI 90 μg;   Drug: AS MDI 180 µg;   Other: Placebo MDI;   Drug: Proventil 90 μg;   Drug: Proventil 180 μg Sponsor:   Pearl Therapeutics, Inc. Not yet recruiting

Source: ClinicalTrials.gov - December 6, 2017 Category: Research Source Type: clinical trials